Heikki Seikkula

hearse@utu.fi

Publications

2 of 2

Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy (2016)
- Scientific Reports
Laajala TD, Seikkula H, Sadat FS, Mirtti T, Boström PJ, Elo LL.
(A1 Refereed original research article in a scientific journal)
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy. (2016)
- Modern Pathology
Lahdensuo K, Erickson A, Saarinen I, Seikkula H, Lundin J, Lundin M, Nordling S, Bützow A, Vasarainen H, Boström PJ, Taimen P, Rannikko A, Mirtti T.
(A1 Refereed original research article in a scientific journal)
Differential predictive roles of A- and B-type nuclear lamins in prostate cancer progression (2015)
- PLoS ONE
Saarinen I, Mirtti T, Seikkula H, Boström PJ, Taimen P
(A1 Refereed original research article in a scientific journal)
PSA ja eturauhassyövän verinäytediagnostiikka (2015)
- Duodecim
Seikkula H, Pettersson K, Boström PJ
(A2 Refereed review article in a scientific journal )
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy (2014)
- Urologic Oncology: Seminars and Original Investigations
Seikkula H, Syvänen K, Kurki S, Mirtti T, Taimen P, Laato M, Boström P
(A1 Refereed original research article in a scientific journal)